Histamine facilitates consolidation of fear extinction

International Journal of Neuropsychopharmacology

Volumn 14, Issue 9, 2011, Pages 1209-1217

  Bonini, Juliana Sartori ^a,b   Da Silva, Weber Cláudio ^a,c   Da Silveira, Clarice Kras Borges ^a   Köhler, Cristiano André ^a   Izquierdo, Iván ^a,c   Cammarota, Martín ^a,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE ESTADUAL DO CENTRO OESTE   (Brazil)

^c Fellow of the National Research Council   (Brazil)

Author keywords

ERK; extinction; hippocampus; histamine; memory

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 2 PYRIDYLETHYLAMINE; DIMAPRIT; HISTAMINE; HISTAMINE H1 RECEPTOR AGONIST; HOMODIMAPRIT; IFENPRODIL; IMETIT; MITOGEN ACTIVATED PROTEIN KINASE 3; RANITIDINE; THIOPERAMIDE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; HISTAMINE AGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE METHYLTRANSFERASE; NERVE PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; DRUG INHIBITION; DRUG MECHANISM; FEAR; HIPPOCAMPUS; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPAL CA1 REGION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NERVE CELL; NERVE CELL INHIBITION; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CA1 REGION, HIPPOCAMPAL; ENZYME INHIBITORS; FEAR; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE H2 ANTAGONISTS; HISTAMINE N-METHYLTRANSFERASE; INFUSIONS, INTRAVENTRICULAR; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEURONS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3; SIGNAL TRANSDUCTION;

EID: 84856074783     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001501     Document Type: Article

References (49)

1. Alvarez EO, Ruarte MB (2002). Histaminergic neurons of the ventral hippocampus and the baso-lateral amygdala of the rat : functional interaction on memory and learning mechanisms. Behavioural Brain Research 128, 81-90. (Pubitemid 34033637)
2. Alvarez EO, Ruarte MB, Banzan AM (2001). Histaminergic systems of the limbic complex on learning and motivation. Behavioural Brain Research 124, 195-202. (Pubitemid 32964638)
3. Baldi E, Bucherelli C, Schunack W, Cenni G, et al. (2005). The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat. Neuropharmacology 48, 246-251. (Pubitemid 40208260)
4. Banthin JS, Miller GE (2006). Trends in prescription drug expenditures by Medicaid enrollees. Medical Care 44, I27-I35. (Pubitemid 43755410)
5. Bender BG (2005). Cognitive effects of allergic rhinitis and its treatment. Immunology and Allergy Clinics of North America 25, 301-312. (Pubitemid 40692711)
6. Berlese DB, Sauzem PD, Carati MC, Guerra GP, et al. (2005). Time-dependent modulation of inhibitory avoidance memory by spermidine in rats. Neurobiology of Learning and Memory 83, 48-53. (Pubitemid 40018026)
7. Braga PC, Soldavini E, Pecile A, Sibilia V, et al. (1996). Involvement of H1 receptors in the central antinociceptive effect of histamine : pharmacological dissection by electrophysiological analysis. Experientia 52, 60-65.
8. Brown RE, Stevens DR, Haas HL (2001). The physiology of brain histamine. Progress in Neurobiology 63, 637-672. (Pubitemid 32119421)
9. Camera K, Mello CF, Ceretta AP, Rubin MA (2007). Systemic administration of polyaminergic agents modulate fear conditioning in rats. Psychopharmacology 192, 57-64.
10. Cammarota M, Bevilaqua LR, Rossato JI, Ramirez M, et al. (2005). Relationship between short-and long-termmemory and short-and long-term extinction. Neurobiology of Learning and Memory 84, 25-32. (Pubitemid 40776093)
11. Da Silva WC, Bonini JS, Bevilaqua LRM, Izquierdo I, et al. (2006). Histamine enhances inhibitory avoidance memory consolidation through a H2 receptor-dependent mechanism. Hippocampus 86, 100-106. (Pubitemid 43776642)
12. Davis M, Barad M, Otto M, Southwick S (2006). Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches. Journal of Traumatic Stress 19, 571-581. (Pubitemid 46424373)
13. De Almeida MA, Izquierdo I (1986). Memory facilitation by histamine. Archives Internationales de Pharmacodynamie et de Thérapie 283, 193-198. (Pubitemid 16000248)
14. Di Carlo G, Ghi P, Orsetti M (2000). Effect of R-(-)-alphamethylhistamine and thioperamide on in vivo release of norepinephrine in the rat hippocampus. Progress in Neuropsychopharmacology & Biological Psychiatry 24, 275-284. (Pubitemid 30159536)
15. Duch DS, Bowers SW, Nichol CA (1978). Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase. Biochemical Pharmacology 27, 1507-1509. (Pubitemid 8401752)
16. Eidi M, Zarrindast MR, Eidi A, Oryan S, et al. (2003). Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats. European Journal of Pharmacology 465, 91-96. (Pubitemid 36332280)
17. Frémin C, Bessard A, Ezan F, Gailhouste L, et al. 2009, Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signalregulated Kinases ERK1 and ERK2. Hepatology, 49, 930-939.
18. Frisch C, Hasenöhrl RU, Krauth J, Huston JP (1998). Anxiolytic-like behavior after lesion of the tuberomammillary nucleus E2-region. Experimental Brain Research 119, 260-264. (Pubitemid 28098519)
19. Giovannini MG, Efoudebe M, Passani MB, Baldi E, et al. (2003). Improvement in fear memory by histamine elicited ERK2 activation in hippocampal CA3 cells. Journal of Neuroscience 23, 9016-9023. (Pubitemid 37243802)
20. Haas H, Panula P (2003). The role of histamine and the tuberomamillary nucleus in the nervous system. Nature Reviews Neuroscience 4, 121-130. (Pubitemid 37271382)
21. Halpert AG, Olmstead MC, Beninger RJ (2002). Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neuroscience and Biobehavioral Reviews 26, 61-67. (Pubitemid 34130534)
22. Herry C, Trifilieff P, Micheau J, Lüthi A, et al. (2006). Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala. European Journal of Neuroscience 24, 261-269. (Pubitemid 44050685)
23. Huh KH, Guzman YF, Tronson NC, Guedea AL, et al. (2009). Hippocampal Erk mechanisms linking prediction error to fear extinction : roles of shock expectancy and contextual aversive valence. Learning & Memory 16, 273-278.
24. Izquierdo I, Bevilaqua LR, Rossato JI, Bonini JS, et al. (2006). Different molecular cascades in different sites of the brain control memory consolidation. Trends in Neurosciences 29, 496-505. (Pubitemid 44291818)
25. Klapdor K, Hasenöhrl RU, Huston JP (1994). Facilitation of learning in adult and aged rats following bilateral lesions of the tuberomammillary nucleus region. Behavioural Brain Research 61, 113-116. (Pubitemid 24097025)
26. Knoche A, Yokoyama H, Ponomarenko A, Frisch C, et al. (2003). High-frequency oscillation in the hippocampus of the behaving rat and its modulation by the histaminergic system. Hippocampus 13, 273-280. (Pubitemid 36503539)
27. Krens SF, He S, Lamers GE, Meijer AH, et al. (2008). Distinct functions for ERK1 and ERK2 in cell migration processes during zebrafish gastrulation. Developmental Biology 319, 370-383.
28. Lefloch R, Pouysségur J, Lenormand P (2008). Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Molecular and Cellular Biology 28, 511-527.
29. Lieberman P (2009). Histamine, antihistamines, and the central nervous system. Allergy and Asthma Proceedings 30, 482-486.
30. Malmberg-Aiello P, Lamberti C, Ipponi A, Hanninen J, et al. (1997). Effects of two histamine-N-methyltransferase inhibitors, SKF 91488 and BW 301 U, in rodent antinociception. Naunyn-Schmiedeberg's Archives of Pharmacology 355, 354-360. (Pubitemid 27117593)
31. Marchi M, D'Antoni A, Formentini I, Parra R, et al. (2008). The N-terminal domain of ERK1 accounts for the functional differences with ERK2. PLoS ONE 3, e3873.
32. Maren S, Quirk GJ (2004). Neuronal signalling of fear memory. Nature Reviews Neuroscience 5, 844-852. (Pubitemid 39482153)
33. Morishita W, Lu W, Smith GB, Nicoll RA, et al. (2007). Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology 52, 71-76. (Pubitemid 46026821)
34. Panula P, Pirvola U, Auvinen S, Airaksinen MS (1989). Histamine immunoreactive nerve fibers in the rat brain. Neuroscience 28, 585-610. (Pubitemid 19081018)
35. Passani MB, Giannoni P, Bucherelli C, Baldi E, et al. (2007). Histamine in the brain : beyond sleep and memory. Biochemical Pharmacology 73, 1113-1122. (Pubitemid 46413174)
36. Pavlov IP (1928). Lectures on Conditioned Reflexes. New York: Liveright.
37. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. San Diego, USA: Academic Press.
38. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 14, 149-167. (Pubitemid 16239568)
39. Quirk GJ, Mueller D (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56-72. (Pubitemid 350191313)
40. Rowe MK, Craske MG (1998). Effects of an expandingspaced vs. massed exposure schedule on fear reduction and return of fear. Behaviour Research and Therapy 36, 701-717. (Pubitemid 28339790)
41. Selcher JC, Nekrasova T, Paylor R, Landreth GE, et al. (2001). Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learning & Memory 8, 11-19. (Pubitemid 32167883)
42. Sotres-Bayon F, Diaz-Mataix L, Bush DE, LeDoux JE (2009). Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction : NR2B contribution. Cerebral Cortex 19, 474-482.
43. Sweatt JD (2001). Memory mechanisms: the yin and yang of protein phosphorylation. Current Biology 11, R391-R394. (Pubitemid 32442783)
44. Tran DH, Gong R, Tang SJ (2007). Differential roles of NR2A and NR2B subtypes in NMDA receptor-dependent protein synthesis in dendrites. Neuropharmacology 53, 252-256. (Pubitemid 47187451)
45. Tronson NC, Schrick C, Fischer A, Sananbenesi F, et al. (2008). Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology 33, 1570-1583. (Pubitemid 351684712)
46. Van Ruitenbeek P, Vermeeren A, Riedel W (2008). Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. Journal of Psychopharmacology 22, 663-672.
47. Vantaggiato C, Formentini I, Bondanza A, Bonini C, et al. (2006). ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. Journal of Biology 5, 14.
48. Zarrindast MR, Eidi M, Eidi A, Oryan S (2002). Effects of histamine and opioid systems on memory retention of passive avoidance learning in rats. European Journal of Pharmacology 452, 193-197. (Pubitemid 35283930)
49. Zhang L, Meng K, Li YH, Han TZ (2009). NR2A-containing NMDA receptors are required for L-LTP induction and depotentiation in CA1 region of hippocampal slices. European Journal of Neuroscience 29, 2137-2144.